Searching News Database: Eli Lilly
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 28 May 2019
Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics
Lilly Announces Licensing Agreement for Non-Opioid Pain Asset from Centrexion Therapeutics
HSMN NewsFeed - 24 Apr 2019
OncoSec Appoints Industry Veteran Margaret R. Dalesandro, Ph.D., to its Board of Directors
OncoSec Appoints Industry Veteran Margaret R. Dalesandro, Ph.D., to its Board of Directors
HSMN NewsFeed - 2 Apr 2019
Petra Pharma Strengthens Management Team with Recent Leadership Appointments
Petra Pharma Strengthens Management Team with Recent Leadership Appointments
HSMN NewsFeed - 1 Apr 2019
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer
Artios Pharma Announces Appointment of Dr. Ian Smith as Chief Medical Officer
HSMN NewsFeed - 27 Mar 2019
Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer
Synspira Therapeutics Announces Appointment of Robert Gallotto as President and Chief Executive Officer
HSMN NewsFeed - 19 Feb 2019
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
HSMN NewsFeed - 7 Feb 2019
Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
HSMN NewsFeed - 18 Jan 2019
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO(R)
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO(R)
HSMN NewsFeed - 2 Jan 2019
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
Correvio Announces Chief Executive Officer Succession Plan and Other Board and Executive Changes
HSMN NewsFeed - 14 Dec 2018
Lilly and Evidation Health Expand Collaboration to Analyze Data from Smartphones and Connected Sensors
Lilly and Evidation Health Expand Collaboration to Analyze Data from Smartphones and Connected Sensors
HSMN NewsFeed - 8 Nov 2018
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
HSMN NewsFeed - 16 Aug 2018
Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer
Synthorx Appoints Immuno-Oncology Veteran Joseph Leveque, M.D., as Chief Medical Officer
HSMN NewsFeed - 30 Jul 2018
Enzyvant Expands Leadership Team with Appointments of Andrew Dawson and Alex Tracy
Enzyvant Expands Leadership Team with Appointments of Andrew Dawson and Alex Tracy
HSMN NewsFeed - 12 Jun 2018
Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease
Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease
HSMN NewsFeed - 27 Apr 2018
Hill-Rom Appoints John Groetelaars As President And Chief Executive Officer
Hill-Rom Appoints John Groetelaars As President And Chief Executive Officer
HSMN NewsFeed - 26 Mar 2018
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
FDA approves inclusion of data from safety outcomes trial in the Tresiba(R) label
HSMN NewsFeed - 9 Mar 2018
Maura Dickler, M.D., to become Vice President of Late Phase Development at Lilly Oncology
Maura Dickler, M.D., to become Vice President of Late Phase Development at Lilly Oncology
HSMN NewsFeed - 8 Mar 2018
EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research
EFSD, JDRF and Lilly Extend Collaboration Supporting Type 1 Diabetes Research
HSMN NewsFeed - 20 Nov 2017
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
United Therapeutics Announces Additional Six Months Of Regulatory Exclusivity For Adcirca(R)
HSMN NewsFeed - 10 Nov 2017
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
Elanco, Aratana Announce Positive Opinion on GALLIPRANT(R) (grapiprant tablets) in Europe
HSMN NewsFeed - 9 Nov 2017
Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
Neurimmune Announces Collaboration With Ono Pharmaceutical in Neurodegenerative Diseases Field
HSMN NewsFeed - 29 Sep 2017
Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing
Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing
HSMN NewsFeed - 10 Jul 2017
FDA Grants Priority Review for Lilly's Abemaciclib for the Treatment of Advanced Breast Cancer
FDA Grants Priority Review for Lilly's Abemaciclib for the Treatment of Advanced Breast Cancer
HSMN NewsFeed - 10 May 2017
Leigh Ann Pusey Joins Lilly as Senior Vice President of Corporate Affairs and Communications
Leigh Ann Pusey Joins Lilly as Senior Vice President of Corporate Affairs and Communications
HSMN NewsFeed - 30 Mar 2017
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
HSMN NewsFeed - 1 Mar 2017
Perrigo Announces FDA Final Approval For The Generic Version Of Axiron(R) Topical Solution, 30 mg/1.5 mL
Perrigo Announces FDA Final Approval For The Generic Version Of Axiron(R) Topical Solution, 30 mg/1.5 mL
HSMN NewsFeed - 23 Feb 2017
Zomedica Appoints Robert DiMarzo as Executive Vice President of Global Strategy
Zomedica Appoints Robert DiMarzo as Executive Vice President of Global Strategy
HSMN NewsFeed - 6 Feb 2017
Idera Announces Appointment of Jonathan Yingling, Ph.D. as Senior Vice President of Early Development
Idera Announces Appointment of Jonathan Yingling, Ph.D. as Senior Vice President of Early Development
HSMN NewsFeed - 18 Jan 2017
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid
HSMN NewsFeed - 9 Dec 2016
Lilly and AstraZeneca to Develop Second Potentially Disease-Modifying Treatment for Alzheimer's Disease
Lilly and AstraZeneca to Develop Second Potentially Disease-Modifying Treatment for Alzheimer's Disease
HSMN NewsFeed - 8 Nov 2016
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
BD Launches First Syringe Designed for Use with Humulin(R) R U-500 Insulin
HSMN NewsFeed - 31 Oct 2016
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
Antares Pharma Appoints Fred M. Powell, Senior Vice President and Chief Financial Officer
HSMN NewsFeed - 26 Oct 2016
Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth
Actinium Pharmaceuticals Announces New Hires As Supply Chain Organization Expands To Accommodate Growth
HSMN NewsFeed - 15 Aug 2016
Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer
Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer
HSMN NewsFeed - 27 Jul 2016
John C. Lechleiter to Retire as Lilly CEO; Board Elects David A. Ricks as Successor
John C. Lechleiter to Retire as Lilly CEO; Board Elects David A. Ricks as Successor
HSMN NewsFeed - 13 Jul 2016
Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
Lilly and Boehringer Ingelheim Announce Clinical Trial Collaboration in Metastatic Breast Cancer
HSMN NewsFeed - 21 Jun 2016
Neurotrope Appoints Paula T. Trzepacz, M.D. as Executive Vice President and Chief Medical Officer
Neurotrope Appoints Paula T. Trzepacz, M.D. as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 15 Jun 2016
German Supreme Court Grants Lilly Appeal in Alimta(R) Vitamin Regimen Patent Lawsuit
German Supreme Court Grants Lilly Appeal in Alimta(R) Vitamin Regimen Patent Lawsuit
HSMN NewsFeed - 6 Apr 2016
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
Merck and Sysmex Inostics Receive CE Mark Approval for Liquid Biopsy test for Colorectal Cancer Patients
HSMN NewsFeed - 26 Feb 2016
Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis
Lilly Receives Positive CHMP Opinion for Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis
HSMN NewsFeed - 5 Feb 2016
Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed
Novogen Announces Changes to the Board with New Chairman and Deputy Chairman Appointed
HSMN NewsFeed - 11 Jan 2016
Industry Veteran Sherry Korczynski Joins Eagle Pharmaceuticals as Senior Vice President of Marketing
Industry Veteran Sherry Korczynski Joins Eagle Pharmaceuticals as Senior Vice President of Marketing
HSMN NewsFeed - 21 Dec 2015
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
HSMN NewsFeed - 18 Dec 2015
ARIAD Names Paris Panayiotopoulos as Its President and Chief Executive Officer
ARIAD Names Paris Panayiotopoulos as Its President and Chief Executive Officer
HSMN NewsFeed - 17 Dec 2015
Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer
Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer
HSMN NewsFeed - 16 Dec 2015
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 10 Dec 2015
Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA(R) Combination Trial
Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA(R) Combination Trial
HSMN NewsFeed - 2 Dec 2015
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
vTv Therapeutics Announces Larry Altstiel to Serve As Chief Medical Officer
HSMN NewsFeed - 16 Oct 2015
Eli Lilly and Company Expands New York City Research and Development Site
Eli Lilly and Company Expands New York City Research and Development Site
HSMN NewsFeed - 21 Sep 2015
Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel Oncology Pipeline
Deciphera Pharmaceuticals Announces $75 Million Series B Financing to Advance Novel Oncology Pipeline
HSMN NewsFeed - 10 Sep 2015
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
Agilis Biotherapeutics Appoints Arthur Tzianabos, Ph.D., to the Board of Directors
HSMN NewsFeed - 8 Sep 2015
Vanda Pharmaceuticals Announces the Appointment of European General Manager
Vanda Pharmaceuticals Announces the Appointment of European General Manager
HSMN NewsFeed - 27 Aug 2015
Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer
Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer
HSMN NewsFeed - 16 Jul 2015
Immunocore Secures $320 Million (£205 Million) in Europe's Largest Private Life Sciences Financing
Immunocore Secures $320 Million (£205 Million) in Europe's Largest Private Life Sciences Financing
HSMN NewsFeed - 6 Jul 2015
Tadataka Yamada, Ph.D., Former Head of GlaxoSmithKline and Takeda R&D, Re-Joins Frazier Healthcare
Tadataka Yamada, Ph.D., Former Head of GlaxoSmithKline and Takeda R&D, Re-Joins Frazier Healthcare
HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
HSMN NewsFeed - 2 Oct 2014
Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies
Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies
HSMN NewsFeed - 3 Sep 2014
Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer
Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer
HSMN NewsFeed - 18 Aug 2014
Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board
Boston Therapeutics Appoints Noted Diabetes Specialist Jaime A. Davidson, M.D. to Its Medical Advisory Board
HSMN NewsFeed - 14 Aug 2014
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
HSMN NewsFeed - 21 Apr 2014
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
HSMN NewsFeed - 16 Apr 2014
Astellas US Promotes Jeffrey Bloss to SVP of Medical Affairs for the Americas
Astellas US Promotes Jeffrey Bloss to SVP of Medical Affairs for the Americas
HSMN NewsFeed - 7 Apr 2014
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
Deciphera Pharmaceuticals Appoints Michael D. Taylor, Ph.D., as President and Chief Executive Officer
HSMN NewsFeed - 13 Mar 2014
Synergy Pharmaceuticals Appoints Marino Garcia as Senior Vice President, Corporate Development
Synergy Pharmaceuticals Appoints Marino Garcia as Senior Vice President, Corporate Development
HSMN NewsFeed - 4 Mar 2014
Teva Announces Approval of Generic Evista(R) Tablets 60 mg in the United States
Teva Announces Approval of Generic Evista(R) Tablets 60 mg in the United States
HSMN NewsFeed - 19 Feb 2014
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
HSMN NewsFeed - 10 Feb 2014
Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data
Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data
HSMN NewsFeed - 31 Jan 2014
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit
Eli Lilly and Company Provides Statement in Response to Sanofi U.S. Lawsuit
HSMN NewsFeed - 13 Jan 2014
Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics
Lilly Announces Acquisition of CGRP Antibody for Migraine Prevention from Arteaus Therapeutics
HSMN NewsFeed - 8 Nov 2013
EMD Serono Announces Appointment of Paris Panayiotopoulos as President and Managing Director
EMD Serono Announces Appointment of Paris Panayiotopoulos as President and Managing Director
HSMN NewsFeed - 26 Jul 2013
Adimab Announces First Antibody Technology Transfer and License Agreement with GlaxoSmithKline
Adimab Announces First Antibody Technology Transfer and License Agreement with GlaxoSmithKline
HSMN NewsFeed - 26 Jul 2013
Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
HSMN NewsFeed - 19 Feb 2013
MethylGene Announces the Appointment of Mark J. Gergen, as Executive Vice President and COO
MethylGene Announces the Appointment of Mark J. Gergen, as Executive Vice President and COO
HSMN NewsFeed - 10 Dec 2012
TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
HSMN NewsFeed - 18 Oct 2012
Omeros Adds Vice Presidents of Regulatory and Clinical to Management Team
Omeros Adds Vice Presidents of Regulatory and Clinical to Management Team
HSMN NewsFeed - 18 Sep 2012
Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
Biopharmaceutical Industry Veterans Join Inspiration Biopharmaceuticals Board of Directors
HSMN NewsFeed - 17 Sep 2012
Cook Pharmica Names Victor Vinci Vice President and Chief Scientific Officer
Cook Pharmica Names Victor Vinci Vice President and Chief Scientific Officer
HSMN NewsFeed - 24 Aug 2012
ZELTIQ(R) Aesthetics Appoints Mark J. Foley as President and Chief Executive Officer
ZELTIQ(R) Aesthetics Appoints Mark J. Foley as President and Chief Executive Officer
HSMN NewsFeed - 24 Jul 2012
Oncothyreon Appoints Guy Cipriani as Vice President, Business Development
Oncothyreon Appoints Guy Cipriani as Vice President, Business Development
HSMN NewsFeed - 24 Jul 2012
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
HSMN NewsFeed - 21 Jun 2012
Clarus Therapeutics Appoints Bela S. Denes, M.D. as Chief Medical Officer
Clarus Therapeutics Appoints Bela S. Denes, M.D. as Chief Medical Officer
HSMN NewsFeed - 30 May 2012
Kona Medical Secures $30M in Financing to Pursue Novel Hypertension Therapy
Kona Medical Secures $30M in Financing to Pursue Novel Hypertension Therapy
HSMN NewsFeed - 28 Mar 2012
Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors
Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors
HSMN NewsFeed - 27 Mar 2012
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
HSMN NewsFeed - 7 Feb 2012
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
HSMN NewsFeed - 30 Nov 2011
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
SAGE Therapeutics Appoints Chief Scientific Officer, Strengthens Management Team
HSMN NewsFeed - 8 Nov 2011
Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer
HSMN NewsFeed - 25 Oct 2011
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
Lilly Announces Withdrawal of Xigris(R) Following Recent Clinical Trial Results
HSMN NewsFeed - 18 Oct 2011
EBR Systems, Inc. Appoints Allan Will President and Chief Executive Officer
EBR Systems, Inc. Appoints Allan Will President and Chief Executive Officer
HSMN NewsFeed - 26 Sep 2011
Easton Pharmaceuticals Strengthens Sales Capabilities With Key Management Team Addition
Easton Pharmaceuticals Strengthens Sales Capabilities With Key Management Team Addition
HSMN NewsFeed - 13 Sep 2011
Alvine Pharmaceuticals Appoints James D. Watson as Senior Vice President and Chief Business Officer
Alvine Pharmaceuticals Appoints James D. Watson as Senior Vice President and Chief Business Officer
HSMN NewsFeed - 12 Sep 2011
FibroGen Appoints Michael Martinelli, Ph.D., Vice President of Technical Development
FibroGen Appoints Michael Martinelli, Ph.D., Vice President of Technical Development
HSMN NewsFeed - 28 Jul 2011
Ramona M. Lloyd, Ph.D., RAC, Joins Omthera Pharmaceuticals as Vice President Regulatory Affairs
Ramona M. Lloyd, Ph.D., RAC, Joins Omthera Pharmaceuticals as Vice President Regulatory Affairs
HSMN NewsFeed - 15 Jun 2011
Endocyte Names Binh Nguyen, M.D., Ph.D. as Vice President of Clinical Affairs
Endocyte Names Binh Nguyen, M.D., Ph.D. as Vice President of Clinical Affairs
HSMN NewsFeed - 9 Jun 2011
Northwest Biotherapeutics Announces Change and Expansion of Management Team
Northwest Biotherapeutics Announces Change and Expansion of Management Team
HSMN NewsFeed - 29 Apr 2011
Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
HSMN NewsFeed - 11 Apr 2011
Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
HSMN NewsFeed - 18 Mar 2011
Lilly and Avid Receive Complete Response Letter from FDA for Amyvid (florbetapir F 18 injection)
Lilly and Avid Receive Complete Response Letter from FDA for Amyvid (florbetapir F 18 injection)
HSMN NewsFeed - 9 Mar 2011
2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery
2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery
HSMN NewsFeed - 17 Feb 2011
AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
HSMN NewsFeed - 8 Feb 2011
Positron’s Attrius(R) PET Scanner Seeks Market Expansion into Neurologic Imaging
Positron’s Attrius(R) PET Scanner Seeks Market Expansion into Neurologic Imaging
HSMN NewsFeed - 2 Feb 2011
Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
HSMN NewsFeed - 1 Feb 2011
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
Constellation Pharmaceuticals Expands Leadership Team with Drug Development Industry Veterans
HSMN NewsFeed - 1 Dec 2010
Delcath Names Bernard R. Tyrrell as Senior Vice President for North American Sales and Marketing
Delcath Names Bernard R. Tyrrell as Senior Vice President for North American Sales and Marketing
HSMN NewsFeed - 24 Nov 2010
Bausch & Lomb Names Charl van Zyl as Commercial Leader, Europe, Middle East and Africa
Bausch & Lomb Names Charl van Zyl as Commercial Leader, Europe, Middle East and Africa
HSMN NewsFeed - 17 Nov 2010
PolyMedix Appoints Steffen Helmling, Ph.D. as Vice President of Business Development
PolyMedix Appoints Steffen Helmling, Ph.D. as Vice President of Business Development
HSMN NewsFeed - 21 Oct 2010
Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
Jennerex Names Dr. Mark P. Backer as Senior Vice President of Technical Operations
HSMN NewsFeed - 23 Sep 2010
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
HSMN NewsFeed - 21 Sep 2010
Jeffrey A. Winton Named Vice President of Communications at Eli Lilly and Company
Jeffrey A. Winton Named Vice President of Communications at Eli Lilly and Company
HSMN NewsFeed - 22 Jul 2010
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
HSMN NewsFeed - 20 Jul 2010
Seaside Therapeutics Appoints Leading Industry Executives to its Board of Directors
Seaside Therapeutics Appoints Leading Industry Executives to its Board of Directors
HSMN NewsFeed - 7 Jul 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
HSMN NewsFeed - 1 Jun 2010
Baxter Names New President of Renal Business and New Chief Financial Officer
Baxter Names New President of Renal Business and New Chief Financial Officer
HSMN NewsFeed - 19 May 2010
Allostera Pharma Inc. Appoints Christopher Henney as Chairman of its Board of Directors
Allostera Pharma Inc. Appoints Christopher Henney as Chairman of its Board of Directors
HSMN NewsFeed - 29 Mar 2010
Cadence Pharmaceuticals Appoints Michael L. Eagle to its Board of Directors
Cadence Pharmaceuticals Appoints Michael L. Eagle to its Board of Directors
HSMN NewsFeed - 15 Mar 2010
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
Amylin, Lilly and Alkermes Receive Complete Response Letter From FDA for Exenatide Once Weekly Submission
HSMN NewsFeed - 7 Jan 2010
TYRX Announces the Appointment of Senior Medical Device Executive Robert S. White as President and CEO
TYRX Announces the Appointment of Senior Medical Device Executive Robert S. White as President and CEO
HSMN NewsFeed - 4 Jan 2010
Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent
Boston Scientific Announces Enrollment of First Patient in Post-Approval Study for TAXUS Liberte Stent
HSMN NewsFeed - 23 Dec 2009
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
Lilly, Kowa and Kowa Pharmaceuticals America Announce Co-Promotion and Licensing Agreement
HSMN NewsFeed - 18 Dec 2009
Lilly CFO Derica Rice Assumes Expanded Responsibilities, Promoted to Executive Vice President
Lilly CFO Derica Rice Assumes Expanded Responsibilities, Promoted to Executive Vice President
HSMN NewsFeed - 17 Dec 2009
AMAG Pharmaceuticals, Inc. Announces Appointment of Lesley Russell to Board of Directors
AMAG Pharmaceuticals, Inc. Announces Appointment of Lesley Russell to Board of Directors
HSMN NewsFeed - 14 Dec 2009
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
HSMN NewsFeed - 2 Dec 2009
Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
HSMN NewsFeed - 30 Nov 2009
FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder
HSMN NewsFeed - 6 Nov 2009
EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
HSMN NewsFeed - 27 Oct 2009
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
Cephalon Appoints Bob Repella as Senior Vice President of U.S. Pharmaceutical Operations
HSMN NewsFeed - 21 Sep 2009
Merrimack Pharmaceuticals Names Clet Niyikiza, Ph.D. Senior Vice President, Development
Merrimack Pharmaceuticals Names Clet Niyikiza, Ph.D. Senior Vice President, Development
HSMN NewsFeed - 11 Sep 2009
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
New Data Show Patients With Chronic Low Back Pain Maintained Pain Reduction on Cymbalta(R)
HSMN NewsFeed - 10 Sep 2009
SonoSite Appoints John Bowers, Senior Vice President, Strategic Development and Patient Safety Innovations
SonoSite Appoints John Bowers, Senior Vice President, Strategic Development and Patient Safety Innovations
HSMN NewsFeed - 30 Jul 2009
Eli Lilly & Company and ScinoPharm Taiwan Ltd. Announce Settlement of Gemcitabine Litigation
Eli Lilly & Company and ScinoPharm Taiwan Ltd. Announce Settlement of Gemcitabine Litigation
HSMN NewsFeed - 6 Jul 2009
Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
Lilly Receives Fourth FDA Approval for ALIMTA(R) (pemetrexed for injection)
HSMN NewsFeed - 22 Jun 2009
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
Cadence Pharmaceuticals Announces Appointment of Scott Byrd as Chief Commercial Officer
HSMN NewsFeed - 15 Jun 2009
Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO
Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO
HSMN NewsFeed - 1 Jun 2009
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
UK's NICE Recommends Use of Erbitux for Metastatic Colorectal Cancer Patients
HSMN NewsFeed - 27 May 2009
Agios Pharmaceuticals Appoints David Schenkein, M.D. as CEO and Duncan Higgons as COO
Agios Pharmaceuticals Appoints David Schenkein, M.D. as CEO and Duncan Higgons as COO
HSMN NewsFeed - 26 May 2009
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
HSMN NewsFeed - 21 May 2009
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
HSMN NewsFeed - 29 Apr 2009
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
Amylin and Lilly Announce Plans to Develop Pen Device for Exenatide Once Weekly
HSMN NewsFeed - 22 Apr 2009
Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
Lilly Granted Preliminary Injunction to Prevent Launch of Generic Raloxifene
HSMN NewsFeed - 10 Apr 2009
Molecular Templates Inc. Secures $2.5 Million in Series A Financing from Sant Ventures
Molecular Templates Inc. Secures $2.5 Million in Series A Financing from Sant Ventures
HSMN NewsFeed - 7 Apr 2009
TransMolecular Appoints Robert Radie President and Chief Executive Officer
TransMolecular Appoints Robert Radie President and Chief Executive Officer
HSMN NewsFeed - 26 Mar 2009
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
HSMN NewsFeed - 23 Mar 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
HSMN NewsFeed - 9 Mar 2009
Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
HSMN NewsFeed - 24 Feb 2009
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
HSMN NewsFeed - 23 Feb 2009
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
HSMN NewsFeed - 23 Feb 2009
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
HSMN NewsFeed - 3 Feb 2009
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
HSMN NewsFeed - 15 Jan 2009
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
Lilly Resolves Investigations of Past Zyprexa Marketing and Promotional Practices
HSMN NewsFeed - 13 Jan 2009
Jennerex Appoints Samantha Miller as Vice President of Corporate Development
Jennerex Appoints Samantha Miller as Vice President of Corporate Development
HSMN NewsFeed - 8 Jan 2009
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
Satori Pharmaceuticals Raises $22M; Names Former Senior Pfizer Executive as CEO
HSMN NewsFeed - 31 Dec 2008
FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel
FDA Cardio Renal Advisory Committee to Review Daiichi Sankyo, Lilly Drug Prasugrel
HSMN NewsFeed - 10 Dec 2008
Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)
HSMN NewsFeed - 28 Nov 2008
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain
HSMN NewsFeed - 17 Nov 2008
Lilly Licenses U.S. Rights for Tadalafil PAH Indication to United Therapeutics
Lilly Licenses U.S. Rights for Tadalafil PAH Indication to United Therapeutics
HSMN NewsFeed - 3 Nov 2008
DAIICHI SANKYO Acquires Merck Serono's Cardio-Metabolism Sales Force and Products in Turkey
DAIICHI SANKYO Acquires Merck Serono's Cardio-Metabolism Sales Force and Products in Turkey
HSMN NewsFeed - 8 Oct 2008
Calistoga Pharmaceuticals Appoints Carol G. Gallagher, Pharm. D., Chief Executive Officer
Calistoga Pharmaceuticals Appoints Carol G. Gallagher, Pharm. D., Chief Executive Officer
HSMN NewsFeed - 3 Oct 2008
Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
Lilly and Deciphera Pharmaceuticals Announce Licensing and Collaboration Agreement
HSMN NewsFeed - 29 Sep 2008
FDA Grants Lilly's ALIMTA(R) (Pemetrexed for Injection) Third U.S. Approval
FDA Grants Lilly's ALIMTA(R) (Pemetrexed for Injection) Third U.S. Approval
HSMN NewsFeed - 23 Sep 2008
Greg MacMichael, Ph.D., Joins Cook Pharmica as Vice President of Development, CSO
Greg MacMichael, Ph.D., Joins Cook Pharmica as Vice President of Development, CSO
HSMN NewsFeed - 23 Sep 2008
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
HSMN NewsFeed - 12 Sep 2008
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
CV Therapeutics Announces License Agreement for Ranexa(R) in Europe With Menarini Group
HSMN NewsFeed - 25 Aug 2008
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
Patients Taking Cymbalta(R) Experienced Reduced Chronic Low Back Pain in New Study
HSMN NewsFeed - 22 Aug 2008
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder
HSMN NewsFeed - 13 Aug 2008
Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
HSMN NewsFeed - 7 Aug 2008
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
Sucampo Pharmaceuticals Announces Key Management and Board Appointments at its European Affiliate
HSMN NewsFeed - 28 Jul 2008
FDA Issues Not Approvable Letter for Iloperidone to Vanda Pharmaceuticals
FDA Issues Not Approvable Letter for Iloperidone to Vanda Pharmaceuticals
HSMN NewsFeed - 28 Jul 2008
Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone
HSMN NewsFeed - 27 Jun 2008
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder
HSMN NewsFeed - 17 Jun 2008
The Medicines Company Hires Glyn R. Parkin as Senior Vice President, International Operations
The Medicines Company Hires Glyn R. Parkin as Senior Vice President, International Operations
HSMN NewsFeed - 13 Jun 2008
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study
HSMN NewsFeed - 12 Jun 2008
Lilly and TransPharma Medical Announce Licensing and Development Agreement
Lilly and TransPharma Medical Announce Licensing and Development Agreement
HSMN NewsFeed - 11 Jun 2008
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
NOXXON Pharma AG Announces Licensing and Discovery Collaboration with Eli Lilly and Company
HSMN NewsFeed - 22 May 2008
Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
Bharatt Chowrira Joins Nektar Therapeutics as Chief Operating Officer and Head of PEGylation Business Unit
HSMN NewsFeed - 8 May 2008
FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
HSMN NewsFeed - 6 May 2008
MacroGenics Appoints New Chief Commercial Officer and Chief Financial Officer
MacroGenics Appoints New Chief Commercial Officer and Chief Financial Officer
HSMN NewsFeed - 28 Apr 2008
J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc.
J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc.
HSMN NewsFeed - 16 Apr 2008
Lilly to Streamline Indianapolis Manufacturing and Engineering Operations
Lilly to Streamline Indianapolis Manufacturing and Engineering Operations
Additional items found! 436
Members Archive contains
436 additional stories matching:
Eli Lilly
(Password required)
Eli Lilly
(Password required)
